Table 5.
Authors | Autoimmune diseases | aβ2GPl‐IgG (%) | aβ2GPl‐IgA (%) | aβ2GPl‐IgM (%) |
---|---|---|---|---|
Mankaï et al16 | Celiac disease | 1.6 | 14.3 | 1.6 |
Mankaï et al17 | Systemic lupus erythematosus | 19.8 | 50.9 | ‐ |
Mankaï et al13 | Primary biliary cholangitis | 12.5 | 62.5 | 21.2 |
Mankaï et al18 | Antiphospholipid syndrome | 22 | 83.1 | ‐ |
Present study | Rheumatoid arthritis | 6.7 | 26.7 | 5.6 |